East China's Anhui Province plans to build about ten traditional Chinese medicine (TCM) herb breeding bases from 2022 to 2024, according to a promotion plan for the province's TCM industry.

According to the proposal, Anhui will strive to develop more than 30 varieties of TCM, each with an output value of over 100 million yuan (about 14.05 million U.S. dollars) in three years. It will have over ten enterprises with an annual output of over 1 billion yuan and realize a total value of 400 billion yuan for the TCM industry and services.

The number of industry demonstration bases for local herbs in the province will reach 80. The province will also build a provincial TCM museum and TCM service export bases.

In recent years, the province has continuously improved the TCM industrial chain system and promoted the development of TCM industrial clusters.

As one of the country's major TCM trading and production bases, Bozhou City in Anhui had 206 pharmaceutical companies and realized an output value of 31.68 billion yuan in its TCM production industry at the end of last year.